|
|
| 5-Day | 17,234 |
| 10-Day | 17,559 |
| 30-Day | 21,057 |
| 5-Day | 17,234 |
| 10-Day | 17,559 |
| 30-Day | 21,057 |
| 5-Day | 257,688 |
| 10-Day | 257,731 |
| 30-Day | 297,241 |
| 5-Day | 257,688 |
| 10-Day | 257,731 |
| 30-Day | 297,241 |
| NSE SERIES | LAST PRICE | CHANGE(%) | OPEN | HIGH | LOW | FACE VALUE |
|---|---|---|---|---|---|---|
| N1 | 5.27 | 0.00% | 5.26 | 5.34 | 5.26 | 5 |
| Days | BSE | NSE |
| 30 | 2442.79 | 2443.93 |
| 50 | 2430.27 | 2431.06 |
| 150 | 2271.51 | 2271.96 |
| 200 | 2165.65 | 2166.25 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Dr Reddys Labs
| Consolidated | (Sep '13) Quarterly |
(Mar '13) Yearly |
| Net Sales | 3357.45 | 11626.56 |
| Other Income | 63.67 | 247.90 |
| PBDIT | 736.01 | 2111.23 |
| Net Profit | 690.25 | 1677.62 |
| Total Share Capital | 84.90 |
| Net Worth | 7783.40 |
| Total Debt | 1589.10 |
| Net Block | 2387.00 |
| Investments | 2379.20 |
| Net Current Assets | 4183.10 |
| Total Assets | 9372.50 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 582.10 | 0.67 | 650.00 | 354.23 | 120,562.45 |
| Dr Reddys Labs | 2421.95 | 0.36 | 2545.00 | 1764.00 | 41,197.31 |
| Lupin | 857.85 | 0.29 | 946.35 | 598.00 | 38,446.94 |
| Cipla | 388.40 | 0.23 | 450.00 | 370.95 | 31,185.47 |
| GlaxoSmithKline | 2524.65 | -1.20 | 2899.00 | 2005.00 | 21,384.55 |
| More » | |||||
| Sep' 13 | Jun' 13 | Mar' 13 | Dec' 12 | |
| Promoter | 25.52 | 25.53 | 25.56 | 25.56 |
| FII | 32.56 | 32.69 | 29.66 | 26.17 |
| DII | 8.88 | 8.84 | 11.03 | 13.98 |
| Others | 33.04 | 32.94 | 33.75 | 34.29 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| Franklin India Bluechip Fund (G) | 824,546 |
| DSP BlackRock Top 100 Equity Fund - Regular Plan (G) | 610,510 |
| ICICI Prudential Focused Bluechip Equity Fund (G) | 520,359 |
| HDFC Top 200 Fund (G) | 487,749 |
Dr Reddys Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 41,197.31 crore.The company has reported a consolidated sales of Rs 3357.45 crore and a Net Profit of Rs 690.25 crore for the quarter ended Sep 2013.
The company management includes G V Prasad - Chairman & CEO, Satish Reddy - Vice Chairman & Mng.Director, Anupam Puri - Independent Director, Ashok S Ganguly - Independent Director, Bruce L A Carter - Independent Director, J P Moreau - Independent Director, Kalpana Morparia - Independent Director, Omkar Goswami - Independent Director, Ravi Bhoothalingam - Independent Director, Sridar Iyengar - Independent Director.
It is listed on the BSE with a BSE Code of 500124 and the NSE with an NSE Code of DRREDDY.
Its Registered office is at 8-2-337, Road No. 3,,Banjara Hills Hyderabad,Andhra Pradesh - 500034.
Their Registrars are Bigshare Services Pvt. Ltd.
SET SMS ALERT